Dr B Suresh, President, Pharmacy Council of India, speaks on various issues related to pharma education in India and elaborates on the initiative taken by Pharmacy Council of India (PCI) to bridge the gap between industry and academia, in an interview with Swati Rana.
Brief us on the current scenario of pharma education in India.
The pharmacy education in India is presently in a very challenging phase. Due to an increase in the growth of the pharma industry, there is a growing need for qualified and highly knowledgeable human resource. As a result, there is now a sudden spurt of interest from the students to pursue pharmacy programme in India. Further, job opportunities for engineering based programmes are on the downslide, making it less attractive for students to pursue engineering as a first choice of career option. The sudden influx of interest and consequent increase of demand has resulted in the rush to start new pharmacy colleges in India in an already overcrowded space. This sudden growth has precipitated issues relating to the quality of education being delivered at these institutions. The Pharmacy Council of India (PCI) has addressed this challenge of quality in pharmacy education through a strategy involving three domains of action: quality assurance, academic and institutional capacity building and more emphasis on experiential education and competency building.
What are the issues faced by PCI?
PCI faces a major challenge with regards to dual regulation of pharmacy education, i.e. by the PCI and All India Council for Technical Education (AICTE). This dual regulation has led to institutions exploiting structural and procedural mechanisms of regulation to their advantage, resulting in a number of litigations. Though the PCI and AICTE have worked out strategies to harmonise their regulations it still does precipitate regulatory challenges that result in not being able to bring about quality advancement. Besides this, the major challenge for pharmacy education in the country relates to the availability of qualified and competent pharmacy teachers that can carry forward the vision of PCI in preparing a pharmacist workforce that is competent, current and relevant.
ãã®èšäºã¯ Express Pharma ã® September 1-15, 2017 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Express Pharma ã® September 1-15, 2017 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation